EUVIMEDEUVIMED entdecken
Crossref

1-Palmitoyl-4-piperidinopiperidine exhibits anticancer effects in murine triple-negative breast cancer EO771 cells associated with STAT3 signaling suppression

Hiroki Yoshioka iD, Junya Hamanaka, Ayane Horiuchi, Hanane Horita, Rion Uno, Azumi Noguchi, Yuki Matsushita, Masumi Suzui

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05642-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Hiroki Yoshioka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hygiene, School of Medicine, Kitasato University, 1-15-1 Kitasato, Minami-Ku, Sagamihara, Kanagawa, 252-0374, Japan. yoshioka.hiroki@ki…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Triple Negative Breast Neoplasms, Antineoplastic Agents, Piperidines. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited therapeutic options. An urgent need thus exists to develop novel therapeutic strategies to treat TNBC. We previously demonstrated that 1‑palmitoyl‑4‑piperidinopiperidine (PPI), a derivative of palmitic acid, exerts anticancer effects against human colon carcinoma cells and human pancreatic ductal adenocarcinoma cells by inhibiting signal transducer and activator of transcription 3 (STAT3) phosphorylation. To date, no studies have assessed PPI potency in murine TNBC EO771 cells. We examined cell viability after treatment with PPI for 48 h, and evaluated the expression levels of apoptosis- and cell cycle-related proteins using immunocytochemistry and western blotting. PPI inhibited cell proliferation in a dose-dependent manner, with an IC50 of 3.06 µM. PPI treatment was found to induce apoptosis. We also observed G1 cell cycle arrest as indicated by cyclin D1 and Cdk2 downregulation. Phosphorylated STAT3 levels and those of downstream proteins including CXCR4, MMP2, MMP9, TWIST, VEGF, and Vimentin, decreased following PPI treatment. STAT3 knockdown modestly reduced the sensitivity of EO771 cells to PPI, supporting partial involvement of STAT3 signaling in the anticancer effects of PPI. These results suggest that PPI exerts anticancer effects on EO771 cells that are associated with suppression of STAT3 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorTriple Negative Breast NeoplasmsAntineoplastic AgentsPiperidinesAnimalsSignal TransductionCell Line, TumorApoptosisFemaleCell ProliferationMiceCell SurvivalDose-Response Relationship, DrugPhosphorylation

Stichwörter der Autor:innen

ApoptosisCell cycle arrestPalmitoyl piperidinopiperidineSignal transducer and activator of transcriptionTriple negative breast cancer

Substanzen

STAT3 Transcription FactorAntineoplastic AgentsPiperidinesStat3 protein, mouse

Autor:innen und Institutionen

  • Department of Hygiene, School of Medicine, Kitasato University, 1-15-1 Kitasato, Minami-Ku, Sagamihara, Kanagawa, 252-0374, Japan. yoshioka.hiroki@kitasato-u.ac.jp.
  • Faculty of Pharmacy, Gifu University of Medical Science, 4-3-3 Nijigaoka, Kani, Gifu, 509-0293, Japan. yoshioka.hiroki@kitasato-u.ac.jp.
  • Department of Hygiene, School of Medicine, Kitasato University, 1-15-1 Kitasato, Minami-Ku, Sagamihara, Kanagawa, 252-0374, Japan.
  • Department of Neurotoxicology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-Cho Mizuho-Ku, Nagoya, 467-8601, Japan.
  • Faculty of Pharmacy, Gifu University of Medical Science, 4-3-3 Nijigaoka, Kani, Gifu, 509-0293, Japan.
  • Department of Skeletal Development and Regenerative Biology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8588, Japan.

ORCID-Profile: Hiroki Yoshioka

Zitieren

APA

Yoshioka, H., Hamanaka, J., Horiuchi, A., Horita, H., Uno, R., Noguchi, A., Matsushita, Y., & Suzui, M. (2026). 1-Palmitoyl-4-piperidinopiperidine exhibits anticancer effects in murine triple-negative breast cancer EO771 cells associated with STAT3 signaling suppression. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05642-w

Vancouver

Yoshioka H, Hamanaka J, Horiuchi A, Horita H, Uno R, Noguchi A, et al. 1-Palmitoyl-4-piperidinopiperidine exhibits anticancer effects in murine triple-negative breast cancer EO771 cells associated with STAT3 signaling suppression. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05642-w

BibTeX
@article{Yoshioka2026,
  author = {Yoshioka, Hiroki and Hamanaka, Junya and Horiuchi, Ayane and Horita, Hanane and Uno, Rion and Noguchi, Azumi and Matsushita, Yuki and Suzui, Masumi},
  title = {1-Palmitoyl-4-piperidinopiperidine exhibits anticancer effects in murine triple-negative breast cancer EO771 cells associated with STAT3 signaling suppression},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05642-w}
}
Kostenlos starten →